Pharma Journalist -

Cellevolve Bio a development and commercialization company focused on cell therapies and Seattle Children’s Therapeutics, a venture at Seattle Children's, bringing cutting edge,…
Read More...

SMi Group reports: Key pressing questions on rapid microbial methods, contamination control, sterility assurance and environmental monitoring will be addressed at the Microbiology East…
Read More...

Aldeyra Therapeutics, Inc. announced that it has initiated a Phase 2 clinical trial of ADX-2191 (intravitreal methotrexate 0.8%), an investigational new drug product, for the treatment…
Read More...

ABEC announced it will provide customized, large-scale bioprocess equipment, including a 14,500 liter total volume stainless steel fermenter and an 8,000 liter media preparation system…
Read More...

UCB announced it will build an innovative and environmentally sustainable gene therapy process development and clinical manufacturing facility on their high-tech campus in Braine…
Read More...

Johnson & Johnson announced the completion of a landmark agreement between Janssen Pharmaceuticals, Inc., and manufacturer Aspen SA Operations (Pty) Ltd, based in South Africa, to…
Read More...

Novartis announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids…
Read More...

BioNTech SE announced the expansion of its strategic collaboration with Regeneron to advance the Company’s FixVac candidate BNT116 in combination with Libtayo (cemiplimab), a PD-1…
Read More...

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, announced it received…
Read More...

The European Commission (EC) has granted marketing authorization for Jardiance (empagliflozin) as a treatment for adults with symptomatic chronic heart failure, Boehringer Ingelheim and…
Read More...